Skip to content
Clinical Trials – home

Nemocnice AGEL Novy Jicin a.s.

Verifiedinfo

Czechia Purkynova 2138/16, 741 01 Novy Jicin, Czechia

  • 23 trials recruiting
  • Dermatitis atopic · Psoriasis · Non-small cell lung cancer
  • Adults and children

About Specializations

Nemocnice AGEL Novy Jicin a.s. in Novy Jicin, Czechia specialises in clinical trials of conditions such as Dermatitis atopic, Psoriasis, Non-small cell lung cancer, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Nemocnice AGEL Novy Jicin a.s., investigators are advancing therapies for immune system diseases such as atopic dermatitis and related eczema, testing novel biologic agents to improve skin health and patient quality of life.

  • Atopic Dermatitis
  • Atopic Hand Eczema
  • Moderate-to-severe Atopic Dermatitis

These studies evaluate safety and long‑term effectiveness of subcutaneous biologics compared with placebo, offering participants early access to potentially disease‑modifying treatments.

Neoplasms

The oncology program at Nemocnice AGEL Novy Jicin a.s. addresses a range of neoplasms, including kidney, prostate, endometrial, lung and ovarian cancers, by testing new immunotherapy combinations and targeted drugs aimed at extending survival.

  • Advanced Clear Cell Renal Cell Carcinoma
  • High‑Risk Localized Prostate Cancer
  • Metastatic Castration‑Resistant Prostate Cancer
  • Advanced or Recurrent Endometrial Cancer
  • c‑Met Overexpressing Non‑Squamous NSCLC
  • Platinum‑Sensitive Epithelial Ovarian Cancer
  • Renal Cell Carcinoma Post‑Nephrectomy

Primary goals include measuring progression‑free and overall survival, providing patients with innovative options beyond standard care.

Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases focuses on chronic conditions like atopic dermatitis and severe hand eczema, exploring next‑generation monoclonal antibodies to reduce disease activity.

  • Atopic Dermatitis
  • Atopic Hand Eczema
  • Severe Atopic Dermatitis

Trials use validated severity indices to compare investigational agents with placebo, seeking to broaden therapeutic choices for individuals with persistent skin inflammation.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Purkynova 2138/16741 01 Novy JicinCzechia
Recruiting now
23 trials
Conditions studied
39
Partner status
Verified

More sites in Novy JicinCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

71 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:F. Hoffmann-La Roche AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd8205
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.